title: Neural plasticity maintained high by activation of cyclic AMP-dependent protein kinase: an age-independent, general mechanism in cat striate cortex.
abstract: Adult cats lack ocular dominance plasticity, showing little change in the ocular dominance distribution following monocular deprivation. Ocular dominance plasticity is also lost in kitten visual cortex that has been continuously infused with either catecholaminergic neurotoxin, beta-adrenoreceptor blocker, or inhibitor of cyclic AMP-dependent protein kinase (protein kinase A). Complementarily, in adult cats we showed earlier that pharmacological activation of protein kinase A, albeit partially, restored ocular dominance plasticity. In the present study, we first asked whether, mediated by protein kinase A activation, the same molecular mechanisms could restore ocular dominance plasticity to kitten cortex that once lost the expression of plasticity due to prior pharmacological treatments. Concurrently with monocular deprivation, two kinds of cyclic AMP-related drugs (cholera toxin A-subunit or dibutyryl cyclic AMP) were directly infused in two types of aplastic kitten cortex pretreated with either 6-hydroxydopamine or propranolol. The combined treatment resulted in clear ocular dominance shift to the non-deprived eye, indicating that cortical plasticity was fully restored to aplastic kitten cortex. Next, to directly prove the sensitivity difference in protein kinase A activation between the immature and mature cortex, we compared the thus-obtained data in kittens with the published data derived from adult cats under the comparable experimental paradigm. The extent of ocular dominance changes following monocular deprivation was compared at different drug concentrations in the two preparations: the shifted ocular dominance distribution in aplastic kitten cortex infused with dibutyryl cyclic AMP at the lowest concentration tested and the W-shaped distribution in similarly treated adult cortex at a thousandfold-higher drug concentration that induced nearly maximal changes. We conclude that, irrespective of the animal's age, activation of protein kinase A cascades is a general mechanism to maintain ocular dominance plasticity high, their sensitivity being substantially higher in the immature than mature cortex.
authors.affiliation: Laboratory of Visual Neurocomputing, Brain Science Institute, RIKEN, 2-1 Hirosawa, Wako-shi, Saitama, 351-0198, Japan. imamurak@brain.riken.jp
authors.forename: K
authors.initials: K
authors.lastname: Imamura
authors.forename: T
authors.initials: T
authors.lastname: Kasamatsu
authors.forename: S
authors.initials: S
authors.lastname: Tanaka
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000375:Aging / Q000502:physiology*; D000818:Animals; D001931:Brain Mapping; D003994:Bucladesine / Q000494:pharmacology; D002415:Cats; D002772:Cholera Toxin / Q000494:pharmacology; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism*; D023882:Dominance, Ocular / Q000502:physiology; D004789:Enzyme Activation / Q000502:physiology; D008845:Microinjections; D009473:Neuronal Plasticity / Q000502:physiology*; D016627:Oxidopamine; D010775:Photic Stimulation; D011433:Propranolol / Q000494:pharmacology; D013565:Sympatholytics; D014793:Visual Cortex / Q000254:growth & development / Q000502:physiology*; D014794:Visual Fields / Q000502:physiology
chemical_list: D000319:Adrenergic beta-Antagonists; D013565:Sympatholytics; D003994:Bucladesine; D016627:Oxidopamine; D002772:Cholera Toxin; D011433:Propranolol; D017868:Cyclic AMP-Dependent Protein Kinases